Skip to content

Cerus CERS Common Stock

Common Stock at other companies

CorMedix logo
CorMedixCRMD
160M0.0%
Haemonetics logo
HaemoneticsHAE
$453K-6.0%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$1K0.0%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
126.2M0.0%
ADMA Biologics logo
ADMA BiologicsADMA
300M0.0%
Paysign logo
PaysignPAYS
150M0.0%

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's common stock?
Cerus (CERS) reported common stock of $200K in Q1 2026.
How has Cerus's common stock changed year-over-year?
Cerus's common stock increased by 4.7% year-over-year, from $191K to $200K.
What is the long-term trend for Cerus's common stock?
Over 5 years (2020 to 2025), Cerus's common stock has grown at a 2.7% compound annual growth rate (CAGR), from $168K to $192K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).